Labelling Review row-Online

THE WISE THERANOSTIC CHOICE
A fully automated, robust and dependable IHC test for the accurate assessment of HER2 status in
breast tissue from patients for whom Herceptin® (trastuzumab) treatment is being considered 1
.
• Fully automated – ready-to-use reagents run on the Bond system, standardizing the staining
process and reducing hands-on time, staining variation and repeats
• Consistent – control cell slides with interferometer-verified section thickness and four cell lines
(including 2+) provide a consistent, comprehensive control method for assessing assay performance
• Complete – all the reagents required to perform up to 60 tests on the Bond system 2
.
ORACLE HER2 BOND IHC SYSTEM (TA9145)
Oracle HER2 Bond IHC System – TA9145
• 60 test slides with HER2 Primary Antibody
• 60 test slides with HER2 Negative Control
• 15 HER2 Control Slides with HER2 Primary Antibody
• 15 positive in-house tissue controls with HER2 Primary Antibody
1. See Herceptin ® package insert
2. When used with standard Bond system ancillary reagents
F Frozen I Immunofluorescence E Electron microscopy
P Paraffin C Flow cytometry O Other applications
W Western blotting
/11
Bond